Background: Ventilator associated pneumonia (VAP) is
one of the most common nosocomial infections among patients in Intensive Care
Unit (ICU), which has high mortality rate. Among the common agents, Pseudomonas
aeruginosa (P. aeruginosa) is the most common causative agents of
VAP incidence and resistance to a wide range of antibiotics is increasing. The
aim of this study was to assess the prevalence of P. aeruginosa and its
drug susceptibility pattern.
Methods: This sectional
survey has carried out for a year on ICU patients of Ayatollah Kashani hospital
who received mechanical ventilation during Oct 2010 to Oct 2011. Sixty eight
samples of endotracheal tubes were collected from the patients with signs of
pulmonary infection which included fever, purulent secretions, and
leucocytosis. Samples were cultured and strains isolated were identified by
microbiological standard methods. Antibiotic susceptibility testing was
performed on isolates using disc diffusion method and results were interpreted
using Clinical and Laboratory Standards Institute guidelines. Antibiotics were
grouped into the 4 following categories: 1) Cephalosporins (Ceftazidime,
Cefepime), 2) Fluroquinolones (Ciprofloxacin), 3) Aminoglycosides (Gentamycin,
Tobramycin, and Amikacin) and 4) Carbapenems (Imipenem).
Results: Out of 68 endotracheal samples, VAP was
confirmed in 46 cases (67.7%) of these patients. The most common microorganism
recovered was P. aeruginosa (15 cases, 32.6%), others
were included: Methicillin-resistannt Staphylococcus aureus or MRSA (8
cases, 17/4%), Klebsiella pneumonia (10 cases, 21/7%), Escherichia
coli (7 cases, 15.2%), Enterobacter (3 cases, 6.5%), Acinetobacter
(2 cases, 4.3%) and 1 case of Citobacter (2.3%). 75% of P. aeruginosa
isolated were MDR (resistant to ≥3 classes of antibiotics) and 50% of isolates
were resistant to all classes of antibiotics.
Conclusions: Due to the
increasing prevalence of Pseudomonas MDR, developing strict protocols to
prevent increase in drug resistance bacteria appears to be necessary.
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |